These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2182673

  • 1. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
    Treanor JJ, Roth FK, Betts RF.
    J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
    [Abstract] [Full Text] [Related]

  • 2. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.
    Sears SD, Clements ML, Betts RF, Maassab HF, Murphy BR, Snyder MH.
    J Infect Dis; 1988 Dec; 158(6):1209-19. PubMed ID: 3198936
    [Abstract] [Full Text] [Related]

  • 3. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.
    Edwards KM, Dupont WD, Westrich MK, Plummer WD, Palmer PS, Wright PF.
    J Infect Dis; 1994 Jan; 169(1):68-76. PubMed ID: 8277200
    [Abstract] [Full Text] [Related]

  • 4. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.
    Powers DC, Fries LF, Murphy BR, Thumar B, Clements ML.
    J Clin Microbiol; 1991 Mar; 29(3):498-505. PubMed ID: 2037667
    [Abstract] [Full Text] [Related]

  • 5. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.
    Powers DC, Sears SD, Murphy BR, Thumar B, Clements ML.
    J Clin Microbiol; 1989 Dec; 27(12):2666-71. PubMed ID: 2592535
    [Abstract] [Full Text] [Related]

  • 6. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
    Gorse GJ, Belshe RB, Munn NJ.
    J Clin Microbiol; 1986 Sep; 24(3):336-42. PubMed ID: 3531226
    [Abstract] [Full Text] [Related]

  • 7. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection.
    Clements ML, Betts RF, Murphy BR.
    Lancet; 1984 Mar 31; 1(8379):705-8. PubMed ID: 6143042
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children.
    Edwards KM, Snyder P, Thompson JM, Johnson PR, Wright PF.
    Vaccine; 1986 Mar 31; 4(1):50-4. PubMed ID: 3962451
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates.
    Boonnak K, Paskel M, Matsuoka Y, Vogel L, Subbarao K.
    Vaccine; 2012 Aug 17; 30(38):5603-10. PubMed ID: 22789506
    [Abstract] [Full Text] [Related]

  • 13. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
    Clements ML, Murphy BR.
    J Clin Microbiol; 1986 Jan 17; 23(1):66-72. PubMed ID: 3700610
    [Abstract] [Full Text] [Related]

  • 14. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S, Ainai A, Suzuki T, Kurata T, Hasegawa H.
    Jpn J Infect Dis; 2016 Jan 17; 69(3):165-79. PubMed ID: 27212584
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.
    Lewis KDC, Ortiz JR, Rahman MZ, Levine MZ, Rudenko L, Wright PF, Katz JM, Dally L, Rahman M, Isakova-Sivak I, Ilyushina NA, Matyushenko V, Fry AM, Lindstrom SE, Bresee JS, Brooks WA, Neuzil KM.
    Clin Infect Dis; 2019 Aug 16; 69(5):777-785. PubMed ID: 30481272
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.
    Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF.
    Ann Intern Med; 1992 Oct 15; 117(8):625-33. PubMed ID: 1530193
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.
    Powers DC, Murphy BR, Fries LF, Adler WH, Clements ML.
    J Am Geriatr Soc; 1992 Feb 15; 40(2):163-7. PubMed ID: 1740601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.